Evidence map›Paper›PMID 36209032›Full record

ReviewTrends in parasitology2022

Targeting malaria parasites inside mosquitoes: ecoevolutionary consequences.

Tsukushi Kamiya, Douglas G Paton, Flaminia Catteruccia, Sarah E Reece

Open access · hybridAbstract readReview
In one paragraph

Review in Trends in parasitology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Between their own and the western: the experience of Emberá communities in Chocó with Malaria.Revista peruana de medicina experimental y salud publica · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Microorganisms · 2023
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Tsukushi KamiyaCentre for Interdisciplinary Research in Biology, Collège de France, Paris, France; HRB Clinical Research Facility, National University of Ireland, Galway, Ireland; Institute of Ecology and Evolution, and Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK. Electronic address: tsukushi.kamiya@college-de-france.fr.
Douglas G PatonDepartment of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA.
Flaminia CatterucciaDepartment of Immunology and Infectious Disease, Harvard T. H. Chan School of Public Health, Harvard University, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA.
Sarah E ReeceInstitute of Ecology and Evolution, and Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK. Electronic address: sarah.reece@ed.ac.uk.
Centre for Immunity, Infection and Evolution · GBCollège de France · FRHarvard University · USHoward Hughes Medical Institute · US

Funding

Malaria transmission blocking through mosquito contact with treated surfacesR01AI148646 · NIAID · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI CATTERUCCIA, FLAMINIA · 2020 to 2024
$3.6M
NIAID NIH HHS R01 AI148646Wellcome Trust 202769/Z/16/Z
6 · The paper itself

Abstract

Proof-of-concept studies demonstrate that antimalarial drugs designed for human treatment can also be applied to mosquitoes to interrupt malaria transmission. Deploying a new control tool is ideally undertaken within a stewardship programme that maximises a drug's lifespan by minimising the risk of resistance evolution and slowing its spread once emerged. We ask: what are the epidemiological and evolutionary consequences of targeting parasites within mosquitoes? Our synthesis argues that targeting parasites inside mosquitoes (i) can be modelled by readily expanding existing epidemiological frameworks; (ii) provides a functionally novel control method that has potential to be more robust to resistance evolution than targeting parasites in humans; and (iii) could extend the lifespan and clinical benefit of antimalarials used exclusively to treat humans.

Indexed as

AntimalarialsCulicidaeMalariaParasitesAnimalsHumansAntimalarialsdrug resistanceepidemiologyparasite–vector interactionssporogonytransmissionwithin-vector dynamics

Identifiers

PMID36209032
PMCPMC9815470
OpenAlexW4302024234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.